U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07511816) titled 'A Study of LY4515100 in Participants With Pain Following Third Molar Removal' on March 30.
Brief Summary: The purpose of this study is to evaluate the safety and efficacy of LY4515100 and see how a single oral dose compares with placebo in acute postsurgical pain after removing impacted third molars. For each participant, the study may last approximately 6 weeks and will include a stay in a Clinical Research Unit (CRU) after third molar removal.
Study Start Date: April, 2026
Study Type: INTERVENTIONAL
Condition:
Acute Pain
Molar
Molar, Third
Surgery, Oral
Intervention:
DRUG: LY4515100
Administered Orally
DRUG: Placebo
Admin...